Heidelberg Pharma Competitors and Similar CompaniesClear all

Heidelberg Pharma's competitors and similar companies include APEIRON Biologics, Sunesis Pharmaceuticals, Clovis Oncology and TRACON Pharmaceuticals.

	Heidelberg Pharma Heidelberg Pharma is a drug development company that provides pre-clinical drug discovery and development services for the development of anti-cancer and anti-inflammatory drugs to pharmaceutical and biotechnology industries.	APEIRON Biologics APEIRON Biologics is a biotech company focused on the discovery and development of cancer immunotherapies.	Sunesis Pharmaceuticals Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.	Clovis Oncology Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.	TRACON Pharmaceuticals TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration.
Founding Date	Founding Date 1997	Founding Date 2005	Founding Date 1987	Founding Date 2009	Founding Date 2006
Type	Type Public	Type Private	Type Subsidiary	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech clinical research drug development medical records oncology therapy	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma
Locations	Locations Ladenburg, DE HQ Ladenburg, DE	Locations Wien, AT HQ	Locations South San Francisco, US HQ	Locations Boulder, US HQ Paris, FR München, DE Dublin, IE Milano, IT Madrid, ES Zürich, CH see more	Locations San Diego, US HQ
Employees	Employees 60	Employees 5	Employees 42	Employees 4843% increase	Employees 268% increase
Valuation ($)	Valuation ($) 158.3 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 10.6 m	Valuation ($) 279.4 k
Financial
Revenue (est.)	Revenue (est.) €1.5m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $148.8m (FY, 2021)	Revenue (est.) $12m (FY, 2023)
Net income	Net income (€42.3m) (FY, 2025)	Net income N/A	Net income ($114.8m) (FY, 2021)	Net income ($264.5m) (FY, 2021)	Net income ($3.6m) (FY, 2023)
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 171.7m	Total funding raised $ 357m	Total funding raised $ 41m